RxDoctor Payments Data

Jonathan Morrison, PhD

Vascular Surgery · Rochester, MNNPI 1639684434

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Prytime Medical Devices, Inc. accounts for 67.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $6,325 and has fallen 97.0% since, to $187 in 2025.

$15,527in general payments, 2019–2025

Across 52 payments — averaging $298.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prytime Medical Devices, Inc.$10K
  • Terumo Medical Corporation$4K
  • Zimmer Biomet$437
  • Medtronic$182
  • Abbott$95
  • My01 Inc.$68
  • plus $36 from 1 others
$336,417in research payments, 2019–2025

Across 24 payments — averaging $14,017 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Prytime Medical Devices, Inc.$336K

What the payments were for

  • Consulting fees$3,00019%
  • Speaking & faculty fees$2,00013%
  • Travel & lodging$8,21253%
  • Food & beverage$2,31515%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Prytime Medical Devices, Inc.14$10,420
Terumo Medical Corporation27$4,289
Zimmer Biomet6$437
Medtronic1$182
Abbott2$95
My01 Inc.1$68
Johnson & Johnson1$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,527 in reported general payments places this provider in the 85th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$31,569
Medicare patients
72
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →